BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 25768209)

  • 1. Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation.
    Zhang L; Nichols RG; Correll J; Murray IA; Tanaka N; Smith PB; Hubbard TD; Sebastian A; Albert I; Hatzakis E; Gonzalez FJ; Perdew GH; Patterson AD
    Environ Health Perspect; 2015 Jul; 123(7):679-88. PubMed ID: 25768209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Reveals that Aryl Hydrocarbon Receptor Activation by Environmental Chemicals Induces Systemic Metabolic Dysfunction in Mice.
    Zhang L; Hatzakis E; Nichols RG; Hao R; Correll J; Smith PB; Chiaro CR; Perdew GH; Patterson AD
    Environ Sci Technol; 2015 Jul; 49(13):8067-77. PubMed ID: 26023891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POPs and Gut Microbiota: Dietary Exposure Alters Ratio of Bacterial Species.
    Potera C
    Environ Health Perspect; 2015 Jul; 123(7):A187. PubMed ID: 26131758
    [No Abstract]   [Full Text] [Related]  

  • 4. Dioxin-like polychlorinated biphenyl 126 (PCB126) disrupts gut microbiota-host metabolic dysfunction in mice via aryl hydrocarbon receptor activation.
    Zhang Y; Cui R; Shi G; Dai Y; Dong J; Wu Q; Zhang H; Dai J
    Ecotoxicol Environ Saf; 2022 May; 236():113448. PubMed ID: 35367886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted metabolomics reveals that 2,3,7,8-tetrachlorodibenzofuran exposure induces hepatic steatosis in male mice.
    Yuan P; Dong M; Lei H; Xu G; Chen G; Song Y; Ma J; Cheng L; Zhang L
    Environ Pollut; 2020 Apr; 259():113820. PubMed ID: 31918130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic impact of persistent organic pollutants on gut microbiota.
    Tian Y; Gui W; Rimal B; Koo I; Smith PB; Nichols RG; Cai J; Liu Q; Patterson AD
    Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33295235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran.
    Nichols RG; Zhang J; Cai J; Murray IA; Koo I; Smith PB; Perdew GH; Patterson AD
    Metabolites; 2019 Dec; 10(1):. PubMed ID: 31861317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.
    Li CY; Dempsey JL; Wang D; Lee S; Weigel KM; Fei Q; Bhatt DK; Prasad B; Raftery D; Gu H; Cui JY
    Drug Metab Dispos; 2018 Aug; 46(8):1226-1240. PubMed ID: 29769268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice.
    Yang CW; Liu HM; Chang ZY; Liu GH; Chang HH; Huang PY; Lee TY
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-induced obesity requires farnesoid X receptor.
    Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
    Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
    Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
    mSystems; 2016; 1(5):. PubMed ID: 27822554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice.
    Zhang L; Rimal B; Nichols RG; Tian Y; Smith PB; Hatzakis E; Chang SC; Butenhoff JL; Peters JM; Patterson AD
    Toxicology; 2020 Feb; 431():152365. PubMed ID: 31926186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions.
    Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K
    Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEHP induce cholesterol imbalance via disturbing bile acid metabolism by altering the composition of gut microbiota in rats.
    Yu Z; Shi Z; Zheng Z; Han J; Yang W; Lu R; Lin W; Zheng Y; Nie D; Chen G
    Chemosphere; 2021 Jan; 263():127959. PubMed ID: 32814133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-
    Fling RR; Zacharewski TR
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling.
    Qiu Y; Yu J; Li Y; Yang F; Yu H; Xue M; Zhang F; Jiang X; Ji X; Bao Z
    Ann Med; 2021 Dec; 53(1):508-522. PubMed ID: 33783283
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast β-glucan reduces obesity-associated
    So SY; Wu Q; Leung KS; Kundi ZM; Savidge TC; El-Nezami H
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G639-G655. PubMed ID: 34643089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
    J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.